SCHEMBL6986136

SCHEMBL6986136

Brc1ccc2c(-c3cccnc3)csc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.48
CYP11B2 P19099 1/20 0.48
CYP19A1 P11511 2/20 0.46
MAP3K7 O43318 1/20 0.45
TAB1 Q15750 1/20 0.45
DYRK1A Q13627 1/20 0.44
DYRK1B Q9Y463 1/20 0.44
KMT2A Q03164 4/20 0.42
MEN1 O00255 2/20 0.42
RXFP1 Q9HBX9 2/20 0.42
NPC1 O15118 2/20 0.42
PKM P14618 1/20 0.42
MAPT P10636 4/20 0.42
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP2A6 P11509 4/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2E1 P05181 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6984263 0.99 CYP11B1 (0.47) CYP11B1CYP11B2CYP19A1MAP3K7TAB1
SCHEMBL6985848 0.85 DYRK1A (0.50) CYP11B1CYP11B2CYP19A1MAP3K7TAB1
SCHEMBL6984271 0.84 NPC1 (0.52) CYP11B1CYP11B2CYP19A1MAP3K7TAB1
SCHEMBL6981144 0.82 CYP17A1 (0.50) CYP11B1MAP3K7TAB1DYRK1ADYRK1B
SCHEMBL6985095 0.82 CYP11B1 (0.45) CYP11B1CYP11B2CYP19A1MAP3K7TAB1
SCHEMBL6984570 0.82 MAP3K7 (0.50) CYP11B1CYP11B2CYP19A1MAP3K7TAB1
Hydrochloric Acid SCHEMBL6986821 0.81 CYP17A1 (0.49) CYP11B1MAP3K7TAB1DYRK1ADYRK1B
Hydrochloric Acid SCHEMBL6985047 0.81 CYP11B1 (0.44) CYP11B1CYP11B2CYP19A1MAP3K7TAB1
SCHEMBL507807 0.81 LSS (0.39) CYP19A1MAP3K7TAB1DYRK1ACYP2A6
SCHEMBL6985680 0.80 CYP19A1 (0.50) CYP11B1CYP11B2CYP19A1MAP3K7TAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030130340-A1 Novel benzothiophene derivatives DAIICHI PHARMACEUTICAL CO. LTD. 2003-07-10 US disclosed
EP-1283209-A1 NOVEL BENZOTHIOPHENE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030130340-A1 Novel benzothiophene derivatives CYP17A1, CYP21A2, HSD17B1 CYP11B1 8/4885CYP11B2 18/4885CYP19A1 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.